Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and risk of developing rheumatoid arthritis in antihypertensive drug users

Translated title of the contribution: Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and risk of developing rheumatoid arthritis in antihypertensive drug users

H.J.I. de Jong, R.J. Vandebriel, S.R.F. Saldi, L. van Dijk, H. van Loveren, J.W. Cohen Tervaert, O.H. Klungel

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionAngiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and risk of developing rheumatoid arthritis in antihypertensive drug users
Original languageUndefined/Unknown
Pages (from-to)835-843
Number of pages9
JournalPharmacoepidemiology and Drug Safety
Volume21
Publication statusPublished - 2012

Cite this